Cargando…
Mechanism of action of trabectedin in desmoplastic small round cell tumor cells
BACKGROUND: Desmoplastic small round cell tumor (DSRCT) is a rare and highly aggressive disease, that can be described as a member of the family of small round blue cell tumors. The molecular diagnostic marker is the t(11;22)(p13;q12) translocation, which creates an aberrant transcription factor, EW...
Autores principales: | Uboldi, S., Craparotta, I., Colella, G., Ronchetti, E., Beltrame, L., Vicario, S., Marchini, S., Panini, N., Dagrada, G., Bozzi, F., Pilotti, S., Galmarini, C. M., D’Incalci, M., Gatta, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5294815/ https://www.ncbi.nlm.nih.gov/pubmed/28166781 http://dx.doi.org/10.1186/s12885-017-3091-1 |
Ejemplares similares
-
A systems biology approach to investigate the mechanism of action of trabectedin in a model of myelomonocytic leukemia
por: Mannarino, L, et al.
Publicado: (2018) -
Increased sensitivity to platinum drugs of cancer cells with acquired resistance to trabectedin
por: Colmegna, B, et al.
Publicado: (2015) -
Trabectedin, a drug acting on both cancer cells and the tumour microenvironment
por: D'Incalci, M, et al.
Publicado: (2014) -
Establishment and characterisation of a new patient-derived model of myxoid liposarcoma with acquired resistance to trabectedin
por: Bello, Ezia, et al.
Publicado: (2019) -
Trabectedin and Plitidepsin: Drugs from the Sea that Strike the Tumor Microenvironment
por: Galmarini, Carlos M., et al.
Publicado: (2014)